534 related articles for article (PubMed ID: 19728118)
1. Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women.
Bruyere O; Varela AR; Adami S; Detilleux J; Rabenda V; Hiligsmann M; Reginster JY
Eur J Epidemiol; 2009; 24(11):707-12. PubMed ID: 19728118
[TBL] [Abstract][Full Text] [Related]
2. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
3. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.
Bruyere O; Roux C; Detilleux J; Slosman DO; Spector TD; Fardellone P; Brixen K; Devogelaer JP; Diaz-Curiel M; Albanese C; Kaufman JM; Pors-Nielsen S; Reginster JY
J Clin Endocrinol Metab; 2007 Aug; 92(8):3076-81. PubMed ID: 17566094
[TBL] [Abstract][Full Text] [Related]
4. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
[TBL] [Abstract][Full Text] [Related]
5. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
Watts NB; Geusens P; Barton IP; Felsenberg D
J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
[TBL] [Abstract][Full Text] [Related]
6. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression.
Rabenda V; Bruyère O; Reginster JY
Osteoporos Int; 2011 Mar; 22(3):893-901. PubMed ID: 21060990
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density and vertebral fractures in men.
Legrand E; Chappard D; Pascaretti C; Duquenne M; Rondeau C; Simon Y; Rohmer V; Basle MF; Audran M
Osteoporos Int; 1999; 10(4):265-70. PubMed ID: 10692973
[TBL] [Abstract][Full Text] [Related]
8. Drug efficacies on bone mineral density and fracture rate for the treatment of postmenopausal osteoporosis: a network meta-analysis.
Yang L; Kang N; Yang JC; Su QJ; Liu YZ; Guan L; Liu T; Meng XL; Wang Y; Hai Y
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2640-2668. PubMed ID: 30964193
[TBL] [Abstract][Full Text] [Related]
9. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
[TBL] [Abstract][Full Text] [Related]
10. [Influence on adjacent lumbar bone density after strengthening of T12, L1 segment vertebral osteoporotic compression fracture by percutaneous vertebroplasty and percutaneous kyphoplasty].
Zhang C; Zhu K; Zhou J; Zhou X; Niu G; Wu M; Shao C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):819-23. PubMed ID: 24063170
[TBL] [Abstract][Full Text] [Related]
11. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
[TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
[TBL] [Abstract][Full Text] [Related]
13. Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate.
Bruyère O; Roux C; Badurski J; Isaia G; de Vernejoul MC; Cannata J; Ortolani S; Slosman D; Detilleux J; Reginster JY
Curr Med Res Opin; 2007 Dec; 23(12):3041-5. PubMed ID: 17967221
[TBL] [Abstract][Full Text] [Related]
14. [New spine and non-spine fractures in 871 women/year treated with oral pamidronate plus calcium and vitamin D supplements].
Man Z; Otero AB
Medicina (B Aires); 1997; 57 Suppl 1():32-6. PubMed ID: 9567352
[TBL] [Abstract][Full Text] [Related]
15. Increases in hip and spine bone mineral density are predictive for vertebral antifracture efficacy with ibandronate.
Miller PD; Delmas PD; Huss H; Patel KM; Schimmer RC; Adami S; Recker RR
Calcif Tissue Int; 2010 Oct; 87(4):305-13. PubMed ID: 20737140
[TBL] [Abstract][Full Text] [Related]
16. Quantitative ultrasound at the phalanxes discriminates osteoporotic women with vertebral but not with hip fracture.
Gnudi S; Ripamonti C
Ultrasound Med Biol; 2004 Mar; 30(3):357-61. PubMed ID: 15063517
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.
Palomba S; Orio F; Manguso F; Falbo A; Russo T; Tolino A; Tauchmanovà L; Colao A; Doldo P; Mastrantonio P; Zullo F
Osteoporos Int; 2005 Sep; 16(9):1141-9. PubMed ID: 15928801
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.
Boonen S; Marin F; Mellstrom D; Xie L; Desaiah D; Krege JH; Rosen CJ
J Am Geriatr Soc; 2006 May; 54(5):782-9. PubMed ID: 16696744
[TBL] [Abstract][Full Text] [Related]
19. Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50.
Naves M; Díaz-López JB; Gómez C; Rodríguez-Rebollar A; Cannata-Andía JB
Osteoporos Int; 2005 Dec; 16(12):2013-7. PubMed ID: 16091836
[TBL] [Abstract][Full Text] [Related]
20. Fracture prediction from bone mineral density in Japanese men and women.
Fujiwara S; Kasagi F; Masunari N; Naito K; Suzuki G; Fukunaga M
J Bone Miner Res; 2003 Aug; 18(8):1547-53. PubMed ID: 12929946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
